4.51
전일 마감가:
$4.545
열려 있는:
$4.58
하루 거래량:
1.15M
Relative Volume:
0.97
시가총액:
$398.35M
수익:
$73.48M
순이익/손실:
$-108.30M
주가수익비율:
-2.0044
EPS:
-2.25
순현금흐름:
$-67.17M
1주 성능:
-16.33%
1개월 성능:
-34.26%
6개월 성능:
-8.33%
1년 성능:
+31.49%
Personalis Inc Stock (PSNL) Company Profile
명칭
Personalis Inc
전화
650-752-1300
주소
6600 DUMBARTON CIRCLE, FREMONT, CA
PSNL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PSNL
Personalis Inc
|
4.51 | 389.07M | 73.48M | -108.30M | -67.17M | -2.25 |
![]()
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-15 | 개시 | Guggenheim | Buy |
2025-03-17 | 개시 | Craig Hallum | Buy |
2023-02-06 | 업그레이드 | Needham | Hold → Buy |
2022-01-07 | 업그레이드 | BofA Securities | Neutral → Buy |
2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-11-03 | 다운그레이드 | Needham | Buy → Hold |
2021-10-15 | 재개 | Cowen | Outperform |
2021-09-20 | 재확인 | Needham | Buy |
2021-05-06 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-01-28 | 개시 | Truist | Buy |
2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-11-12 | 재확인 | Needham | Buy |
2020-11-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2020-10-19 | 개시 | Citigroup | Buy |
2020-10-08 | 개시 | BTIG Research | Buy |
2020-08-27 | 개시 | H.C. Wainwright | Buy |
2020-08-18 | 개시 | Needham | Buy |
2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-07-15 | 개시 | BofA/Merrill | Neutral |
2019-07-15 | 개시 | Cowen | Outperform |
2019-07-15 | 개시 | Morgan Stanley | Overweight |
2019-07-15 | 개시 | Oppenheimer | Outperform |
모두보기
Personalis Inc 주식(PSNL)의 최신 뉴스
Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript - MSN
These Analysts Think Personalis, Inc.'s (NASDAQ:PSNL) Sales Are Under Threat - simplywall.st
Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook - MSN
All You Need to Know About Personalis (PSNL) Rating Upgrade to Buy - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - uk.finance.yahoo.com
HC Wainwright & Co. Maintains Buy Rating on Personalis, Lowers Price Target to $8.50 - AInvest
Personalis, Inc. shares fall 1.03% after-hours following a securities lawsuit against Tempus AI, Inc. - AInvest
A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $6 to $9 - 富途牛牛
Personalis Reports Q2 2025 Financial Results - The Globe and Mail
Personalis Earnings Call: Growth Amidst Financial Challenges - TipRanks
Personalis (PSNL) Q2 Revenue Falls 24% - AOL.com
PSNL: HC Wainwright & Co. Lowers Target Price, Maintains Buy Rat - GuruFocus
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - 富途牛牛
Personalis 2025 Q2 Earnings Sustained Losses Despite Sequential Clinical Growth - AInvest
Personalis: Strong Molecular Testing Growth and Strategic MRD Focus Support Buy Rating - TipRanks
Personalis Plunges 26.06% on Revenue Targets - AInvest
Personalis: Q2 Earnings Snapshot - Huron Daily Tribune
Personalis (PSNL) Q2 Revenue Falls 24% - The Motley Fool
Personalis (PSNL): Navigating Near-Term Headwinds, Positioning for MRD Market Domination - AInvest
Personalis' Q2 2025 Earnings Call: Dissecting Contradictions in Revenue Projections and Reimbursement Strategies - AInvest
Personalis Sees 59% Sequential Clinical Test Growth, Targets $70M-$80M in Revenue for 2025 - AInvest
Earnings call transcript: Personalis Q2 2025 reveals revenue miss, stock steady - Investing.com Canada
Personalis Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Personalis Inc. Q2 Financial Performance ReportNews and Statistics - IndexBox
PSNL Predicts Modest Revenue Growth in Q3 - GuruFocus
PERSONALIS Earnings Results: $PSNL Reports Quarterly Earnings - Quiver Quantitative
Personalis earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Personalis reports Q2 EPS (23c), consensus (24c) - TipRanks
Personalis Reports Second Quarter 2025 Financial Results - Yahoo Finance
What are analysts’ price targets for Personalis Inc. in the next 12 monthsNavigate the market with precision tools - Jammu Links News
How does Personalis Inc. compare to its industry peersInvest confidently with real-time updates - Jammu Links News
What drives Personalis Inc. stock priceGet alerts on the hottest stocks daily - Jammu Links News
How strong is Personalis Inc. company’s balance sheetRobust financial gains - Jammu Links News
What are the technical indicators suggesting about Personalis Inc.Unmatched profit growth - Jammu Links News
Is Personalis (NASDAQ:PSNL) Using Too Much Debt? - 富途牛牛
Personalis, Inc. (NASDAQ:PSNL) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing - simplywall.st
What makes Personalis Inc. stock price move sharplyFree Alert Feed for Momentum Based Picks - Newser
Top Risks to Consider Before Buying Personalis Inc. StockTrading Watchlist with Real Time Filters - Newser
Assembly Biosciences (NASDAQ:ASMB) & Personalis (NASDAQ:PSNL) Head-To-Head Contrast - Defense World
Does Personalis Inc. show high probability of reboundFree Low Risk High Return Opportunities - Newser
Key metrics from Personalis Inc.’s quarterly dataWatchlist Summary for Active Day Traders - Newser
News impact scoring models applied to Personalis Inc.Free High Conviction Intraday Stock Signals - Newser
What catalysts could drive Personalis Inc. stock higher in 2025Pre Market Review For Consistent Profits - Jammu Links News
Applying big data sentiment scoring on Personalis Inc.Summary of Consistent Growth Stock Picks - Newser
Why Personalis Inc. is moving todayBuy and Exit Strategy Based on Momentum - Newser
Tempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal Cancer - MSN
Personalis Inc. stock momentum explainedAI Swing Strategy Signal Forecasting System - Newser
Can swing trading help recover from Personalis Inc. lossesIntraday Price Forecast Using Volume Models - Newser
Developing predictive dashboards with Personalis Inc. dataEquity Signal Recap With Long-Term Summary - Newser
Published on: 2025-08-01 02:23:55 - Newser
Personalis Inc (PSNL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):